The Paris System "atypical urothelial cells" category: can the current criteria be improved?

[1]  S. Pambuccian,et al.  Negative predictive value and sensitivity of urine cytology prior to implementation of The Paris System for Reporting Urinary Cytology , 2019, Cancer cytopathology.

[2]  J. Epstein,et al.  Mimickers of urothelial neoplasia. , 2019, Annals of diagnostic pathology.

[3]  S. Rai,et al.  A Quest for Accuracy: Evaluation of The Paris System in Diagnosis of Urothelial Carcinomas , 2019, Journal of cytology.

[4]  Tarek Rahmeh,et al.  Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology , 2018, Diagnostic cytopathology.

[5]  A. Shabaik,et al.  A Single Institutional Experience With the Paris System for Reporting Urinary Cytology: Correlation of Cytology and Histology in 194 Cases , 2018, American journal of clinical pathology.

[6]  F. Brimo,et al.  Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its prediction of subsequent high‐grade urothelial carcinoma , 2018, Cancer cytopathology.

[7]  R. Granados,et al.  Applying the Paris System for Reporting Urine Cytology Increases the Rate of Atypical Urothelial Cells in Benign Cases: A Need for Patient Management Recommendations , 2016, Acta Cytologica.

[8]  F. Brimo,et al.  Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology:  A Correlative Study of 124 Cases. , 2016, American Journal of Clinical Pathology.

[9]  M. Knowles,et al.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity , 2014, Nature Reviews Cancer.

[10]  M. Tötsch,et al.  The Bethesda Terminology for Reporting Thyroid Cytopathology: From Theory to Practice in Europe , 2011, Acta Cytologica.

[11]  F. Brimo,et al.  Accuracy of urine cytology and the significance of an atypical category. , 2009, American journal of clinical pathology.

[12]  Diane Solomon,et al.  The Bethesda interobserver reproducibility study (BIRST) , 2006, Cancer.

[13]  Asghar Keshtkar,et al.  Cellular morphological parameters of the human urinary bladder (malignant and normal) , 2006, International journal of experimental pathology.

[14]  Xue-Ru Wu.  Urothelial tumorigenesis: a tale of divergent pathways , 2005, Nature Reviews Cancer.

[15]  R. Nayar,et al.  Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : The Papanicolaou Society of Cytopathology Practice Guidelines Task Force , 2004, Diagnostic cytopathology.

[16]  J. Epstein,et al.  An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ. , 2001, Human pathology.

[17]  A. Renshaw.  Subclassifying atypical urinary cytology specimens , 2000, Cancer.

[18]  S. Wilczynski,et al.  The accuracy of urinary cytology in daily practice , 1999, Cancer.

[19]  M. Quek,et al.  The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology , 2016, Acta Cytologica.

[20]  Eva M. Wojcik.  What should not be reported as atypia in urine cytology. , 2015, Journal of the American Society of Cytopathology.

[21]  G. Barkan,et al.  Genitourinary cytopathology (kidney and urinary tract). , 2014, Cancer treatment and research.